Tags

Type your tag names separated by a space and hit enter

Probiotics in the treatment of human inflammatory bowel diseases: update 2008.
J Clin Gastroenterol 2008; 42 Suppl 2:S97-103JC

Abstract

Probiotic research and clinical trials have been forging ahead over the last decade. Although much has been learnt in relation to probiotic intestinal epithelial-mucosal immune interactions, the evidence for substantial clinical efficacy of probiotics continues to progress much slower. This review outlines the probiotic clinical studies before 2005 that formed the foundation of probiotic clinical trials in inflammatory bowel disease and then examines indepth those inflammatory bowel disease probiotic clinical trials published after 2005 that are leading to new understanding of the role of probiotics in the induction and remission of inflammatory bowel disease in humans.

Authors+Show Affiliations

Division of Gastroenterology, University of Alberta, Edmonton, Alberta. richard.fedorak@ualberta.caNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

eng

PubMed ID

18542034

Citation

Fedorak, Richard Neil, and Levinus Albert Dieleman. "Probiotics in the Treatment of Human Inflammatory Bowel Diseases: Update 2008." Journal of Clinical Gastroenterology, vol. 42 Suppl 2, 2008, pp. S97-103.
Fedorak RN, Dieleman LA. Probiotics in the treatment of human inflammatory bowel diseases: update 2008. J Clin Gastroenterol. 2008;42 Suppl 2:S97-103.
Fedorak, R. N., & Dieleman, L. A. (2008). Probiotics in the treatment of human inflammatory bowel diseases: update 2008. Journal of Clinical Gastroenterology, 42 Suppl 2, pp. S97-103. doi:10.1097/MCG.0b013e3181618ac7.
Fedorak RN, Dieleman LA. Probiotics in the Treatment of Human Inflammatory Bowel Diseases: Update 2008. J Clin Gastroenterol. 2008;42 Suppl 2:S97-103. PubMed PMID: 18542034.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Probiotics in the treatment of human inflammatory bowel diseases: update 2008. AU - Fedorak,Richard Neil, AU - Dieleman,Levinus Albert, PY - 2008/6/11/pubmed PY - 2008/10/7/medline PY - 2008/6/11/entrez SP - S97 EP - 103 JF - Journal of clinical gastroenterology JO - J. Clin. Gastroenterol. VL - 42 Suppl 2 N2 - Probiotic research and clinical trials have been forging ahead over the last decade. Although much has been learnt in relation to probiotic intestinal epithelial-mucosal immune interactions, the evidence for substantial clinical efficacy of probiotics continues to progress much slower. This review outlines the probiotic clinical studies before 2005 that formed the foundation of probiotic clinical trials in inflammatory bowel disease and then examines indepth those inflammatory bowel disease probiotic clinical trials published after 2005 that are leading to new understanding of the role of probiotics in the induction and remission of inflammatory bowel disease in humans. SN - 1539-2031 UR - https://www.unboundmedicine.com/medline/citation/18542034/Probiotics_in_the_treatment_of_human_inflammatory_bowel_diseases:_update_2008_ L2 - http://Insights.ovid.com/pubmed?pmid=18542034 DB - PRIME DP - Unbound Medicine ER -